166 related articles for article (PubMed ID: 14514724)
1. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice.
Bro S; Bentzon JF; Falk E; Andersen CB; Olgaard K; Nielsen LB
J Am Soc Nephrol; 2003 Oct; 14(10):2466-74. PubMed ID: 14514724
[TBL] [Abstract][Full Text] [Related]
2. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice.
Yu J; Deng M; Zhao J; Huang L
Biochem Biophys Res Commun; 2010 Jan; 391(1):261-6. PubMed ID: 19912987
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Bro S
Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
[TBL] [Abstract][Full Text] [Related]
5. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.
Ivanovski O; Szumilak D; Nguyen-Khoa T; Ruellan N; Phan O; Lacour B; Descamps-Latscha B; Drüeke TB; Massy ZA
Kidney Int; 2005 Jun; 67(6):2288-94. PubMed ID: 15882270
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice.
Bro S; Moeller F; Andersen CB; Olgaard K; Nielsen LB
J Am Soc Nephrol; 2004 Jun; 15(6):1495-503. PubMed ID: 15153560
[TBL] [Abstract][Full Text] [Related]
7. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia.
Buzello M; Törnig J; Faulhaber J; Ehmke H; Ritz E; Amann K
J Am Soc Nephrol; 2003 Feb; 14(2):311-6. PubMed ID: 12538731
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice.
Shah PK; Nilsson J; Kaul S; Fishbein MC; Ageland H; Hamsten A; Johansson J; Karpe F; Cercek B
Circulation; 1998 Mar; 97(8):780-5. PubMed ID: 9498542
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification.
Maizel J; Six I; Slama M; Tribouilloy C; Sevestre H; Poirot S; Giummelly P; Atkinson J; Choukroun G; Andrejak M; Kamel S; Mazière JC; Massy ZA
Circulation; 2009 Jan; 119(2):306-13. PubMed ID: 19118252
[TBL] [Abstract][Full Text] [Related]
10. Effects of apolipoprotein M in uremic atherosclerosis.
Bosteen MH; Madsen Svarrer EM; Bisgaard LS; Martinussen T; Madsen M; Nielsen LB; Christoffersen C; Pedersen TX
Atherosclerosis; 2017 Oct; 265():93-101. PubMed ID: 28866363
[TBL] [Abstract][Full Text] [Related]
11. Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
Nikolov IG; Joki N; Nguyen-Khoa T; Guerrera IC; Maizel J; Benchitrit J; Machado dos Reis L; Edelman A; Lacour B; Jorgetti V; Drüeke TB; Massy ZA
Nephrol Dial Transplant; 2012 Feb; 27(2):505-13. PubMed ID: 21705467
[TBL] [Abstract][Full Text] [Related]
12. Uremia modulates the phenotype of aortic smooth muscle cells.
Madsen M; Aarup A; Albinsson S; Hartvigsen K; Sørensen CM; Turczynska K; Nielsen LB; Pedersen TX
Atherosclerosis; 2017 Feb; 257():64-70. PubMed ID: 28107707
[TBL] [Abstract][Full Text] [Related]
13. Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice.
Zhou J; Møller J; Danielsen CC; Bentzon J; Ravn HB; Austin RC; Falk E
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1470-6. PubMed ID: 11557674
[TBL] [Abstract][Full Text] [Related]
14. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
Bro S; Binder CJ; Witztum JL; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1080-6. PubMed ID: 17347482
[TBL] [Abstract][Full Text] [Related]
16. Arterial disease in chronic renal failure--an experimental study in the rabbit.
Tvedegaard E
Acta Pathol Microbiol Immunol Scand A; 1987; 290():1-28. PubMed ID: 3477940
[TBL] [Abstract][Full Text] [Related]
17. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.
Ivanovski O; Nikolov IG; Joki N; Caudrillier A; Phan O; Mentaverri R; Maizel J; Hamada Y; Nguyen-Khoa T; Fukagawa M; Kamel S; Lacour B; Drüeke TB; Massy ZA
Atherosclerosis; 2009 Jul; 205(1):55-62. PubMed ID: 19118829
[TBL] [Abstract][Full Text] [Related]
18. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.
Bro S; Borup R; Andersen CB; Moeller F; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):570-5. PubMed ID: 16373611
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.
Phan O; Ivanovski O; Nikolov IG; Joki N; Maizel J; Louvet L; Chasseraud M; Nguyen-Khoa T; Lacour B; Drüeke TB; Massy ZA
Nephrol Dial Transplant; 2008 Jan; 23(1):82-90. PubMed ID: 17977878
[TBL] [Abstract][Full Text] [Related]
20. Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice.
Pedersen TX; Bro S; Andersen MH; Etzerodt M; Jauhiainen M; Moestrup S; Nielsen LB
Atherosclerosis; 2009 Feb; 202(2):372-81. PubMed ID: 18489910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
